secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2023-11-09T23:59:59+00:00
Accession:  0001809519-23-000033
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx Q3 revenue $180M; adjusted revenue $190M, net loss $38.5M
----------------------------------------------------------------

- Revenue of $180.0M, reduced by $10M client contract termination; adjusted revenue $190.0M.
- Net loss $38.5M (21.4% margin); adjusted net income $25.5M (13.4% margin).
- Adjusted EBITDA $53.5M (28.1% margin); operating cash flow $60.3M.
- Over 550K prescribers via Provider Mode; >7M consumers of prescription offerings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951923000033/0001809519-23-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951923000033/gdrx-20231109.htm
  HTML page:      https://secwatch.observer/filing/0001809519-23-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer